These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19062480)

  • 1. Invitro evaluation of the neutralising capacity of twenty brands of antacids in Lagos, Nigeria.
    Adepoju-Bello AA; Akpabio UE; Ayoola GA; Coker HA; Enwuru NV
    Nig Q J Hosp Med; 2008; 18(3):153-5. PubMed ID: 19062480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neutralizing capacity and sodium content of antacid brands on the Kenyan market.
    Kibwage IO; Machine A; Hagos B; Hoogmartens J
    East Afr Med J; 1995 Mar; 72(3):194-7. PubMed ID: 7796775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS; Sun P; Yu HY
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations.
    Prieto R; Martinez-Tobed A; Fábregas JL; Beneyto JE
    Arzneimittelforschung; 1984; 34(10A):1360-4. PubMed ID: 6548920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the neutralising capacity of eight brands of antacids.
    Hagos B; Nganga JN; Juma FD; Ndegwa P
    East Afr Med J; 1989 Jun; 66(6):408-10. PubMed ID: 2791947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
    Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
    Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of commercially available antacid tablets.
    Nain CK; Singh K; Verma M; Vinayak VK; Ganguly NK
    Trop Gastroenterol; 1993; 14(4):139-43. PubMed ID: 8171728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutical properties of liquid and tablet antacids: in vivo studies using the intragastric pH-measurement technique.
    Brouwers JR; Tygat GN
    J Pharm Pharmacol; 1978 Mar; 30(3):148-51. PubMed ID: 24686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of seven Oxethazaine containing antacids available in the Indian market.
    Bhoir S; Bhagwat AM
    J Assoc Physicians India; 2013 Jun; 61(6):400-3. PubMed ID: 24640206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing capacity and cost effectiveness of antacids.
    Drake D; Hollander D
    Ann Intern Med; 1981 Feb; 94(2):215-7. PubMed ID: 6781389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antacid action of the aluminum cation: comparison of the in vitro effect of hydroxide and phosphate in open and closed systems].
    Vatier J; Lionnet F; Vitre MT
    Gastroenterol Clin Biol; 1987 Nov; 11(11):758-63. PubMed ID: 3428519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro evaluation of antacid activity in gastric acid secretion in static and dynamic systems].
    Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
    Therapie; 1992; 47(2):99-104. PubMed ID: 1412150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of an aluminum-magnesium containing antacid and gastric mucus: possible contribution to the cytoprotective function of antacids.
    Grübel P; Bhaskar KR; Cave DR; Garik P; Stanley HE; Lamont JT
    Aliment Pharmacol Ther; 1997 Feb; 11(1):139-45. PubMed ID: 9042986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antacid tablets and liquid in fasting and fed men and women.
    Thomson AB; Pinchbeck B; Kirdeikis J; Kirdeikis P; Zuk L; Brunet MK; Jurima-Romet M; Murray PE
    Clin Ther; 1988; 10(2):158-68. PubMed ID: 3273863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An artificial stomach-duodenum model for the in-vitro evaluation of antacids.
    Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
    Aliment Pharmacol Ther; 1992 Aug; 6(4):447-58. PubMed ID: 1420737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.
    Hem SL; White JL; Buehler JD; Luber JR; Grim WM; Lipka EA
    Am J Hosp Pharm; 1982 Nov; 39(11):1925-30. PubMed ID: 7148862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approach for the in vitro evaluation of antacids.
    Vatier J; Vallot T; Vitre MT; Mignon M
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):175-9. PubMed ID: 2185759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of in vitro and in vivo methodology for evaluation of antacids.
    Smyth RD; Herczeg T; Wheatley TA; Hause W; Reavey-Cantwell NH
    J Pharm Sci; 1976 Jul; 65(7):1045-7. PubMed ID: 8626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the acid-neutralizing capacity and other properties of antacids marketed in Morocco.
    Yafout M; Elhorr H; Otmani ISE; Khayati Y
    Med Pharm Rep; 2022 Jan; 95(1):80-87. PubMed ID: 35720246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the antacid effect of raw spinach juice and spinach extract in an artificial stomach model.
    Panda VS; Shinde PM
    J Complement Integr Med; 2016 Dec; 13(4):387-391. PubMed ID: 27404904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.